Q3 2017

Filed Nov 20, 2017 · 10-Q · 51 days after period end · 0001121781-17-000077

Q3 2017 · 10-Q

Revenue

$33.00K

−65.3% vs Q3 2016

Net Income

-$2.37M

N/M vs Q3 2016

EPS Diluted

-$0.35

N/M vs Q3 2016

Gross Profit-$64,000N/M

Operating Income

Same quarter

Metric	Q3 2017	Q3 2016	Q3 2015	Q3 2014
Revenue	$33.00K	$95.00K	$8.00K	$22.00K
Net Income	-$2.37M	-$211.00K	-$2.19M	-$2.97M
EPS Diluted	-$0.35	-$1.36	-$1.75	-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR